| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11008641 | Clinical Nutrition Experimental | 2018 | 9 Pages |
Abstract
Continuous intravenous infusion of alanyl-glutamine at 0.5 and 3.0Â g/kg/day up to 9 consecutive days is safe in a rat model of moderate liver dysfunction based on ANIT-induced cholestasis.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Melanie K. Bothe, Rosa Abele, Heinrich Topp, Johannes Harleman, Martin Westphal, John F. Stover,